| 【Company Research】WuXi Biologics (2269 HK) - Pre-IND and late-stage demand rebounded |
| 【Company Research】Baidu (BIDU US) - Ads business still takes time to recover while Robotaxi and cloud are ramping up nicely |
| 【Company Research】Kanzhun Limited (BZ US) - 2Q25 earnings beat; improving recruitment demand |
| 【Company Research】ZTO Express (ZTO US/2057 HK) - Lower volume guidance but likely ASP surprise |
| 【Company Research】Xiaomi (1810 HK) - 2Q25 in line; Solid EV/IoT momentum offset by softer smartphone outlook |
| 【公司研究】中国生物制药 (1177 HK) - 丰富且差异化的创新管线将持续驱动出海授权交易 |
| 【Company Research】Hansoh Pharma (3692 HK) - Stronger-than-expected BD income in 1H25 |
| 【Company Research】Onewo (2602 HK) - Earnings beat against tough weather; Dividend yield remains attractive |
| 【Company Research】Palo Alto Networks (PANW US) - Solid rev growth and profitability expansion likely to sustain in FY26 |
| 【Company Research】Yancoal Australia (3668 HK) - Weak earnings but largely anticipated; Expect an improvement trend of coal price |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
